Mitsubishi UFJ Asset Management (UK) Ltd. - ANI PHARMACEUTICALS INC ownership

ANI PHARMACEUTICALS INC's ticker is ANIP and the CUSIP is 00182C103. A total of 1 filers reported holding ANI PHARMACEUTICALS INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Mitsubishi UFJ Asset Management (UK) Ltd. ownership history of ANI PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$581
-28.0%
10,000
-33.3%
0.41%
-21.2%
Q2 2023$807
+35.4%
15,0000.0%0.52%
+34.5%
Q1 2023$596
-35.6%
15,000
-34.8%
0.39%
-40.2%
Q4 2022$925
-99.9%
23,0000.0%0.65%
+13.1%
Q3 2022$739,000
+8.4%
23,0000.0%0.57%
+44.9%
Q2 2022$682,000
-99.9%
23,0000.0%0.39%
+35.4%
Q1 2022$646,530,000
+87624.6%
23,000
+43.8%
0.29%
-7.3%
Q4 2021$737,000
+40.4%
16,0000.0%0.31%
+41.4%
Q3 2021$525,000
-44.6%
16,000
+23.1%
0.22%
-49.8%
Q3 2019$947,000
-11.4%
13,0000.0%0.44%
+3300.0%
Q2 2019$1,069,00013,0000.01%
Other shareholders
ANI PHARMACEUTICALS INC shareholders Q4 2023
NameSharesValueWeighting ↓
FIRST WILSHIRE SECURITIES MANAGEMENT INC 327,929$9,218,0003.24%
Parkman Healthcare Partners LLC 107,911$3,033,0000.89%
Global Alpha Capital Management Ltd. 350,231$9,845,0000.85%
MARATHON CAPITAL MANAGEMENT 75,010$2,109,0000.60%
TANG CAPITAL MANAGEMENT LLC 100,000$2,811,0000.56%
EMERALD ADVISERS, LLC 354,045$9,952,0000.38%
Sio Capital Management, LLC 40,000$1,124,0000.37%
EMERALD MUTUAL FUND ADVISERS TRUST 299,493$8,419,0000.37%
Stonepine Capital Management, LLC 26,060$733,0000.30%
Mitsubishi UFJ Asset Management (UK) Ltd. 23,000$646,530,0000.29%
View complete list of ANI PHARMACEUTICALS INC shareholders